IL312349B2 - The cause of least accumulation and use - Google Patents

The cause of least accumulation and use

Info

Publication number
IL312349B2
IL312349B2 IL312349A IL31234924A IL312349B2 IL 312349 B2 IL312349 B2 IL 312349B2 IL 312349 A IL312349 A IL 312349A IL 31234924 A IL31234924 A IL 31234924A IL 312349 B2 IL312349 B2 IL 312349B2
Authority
IL
Israel
Prior art keywords
amino acid
sequence
amino acids
positions
seq
Prior art date
Application number
IL312349A
Other languages
English (en)
Hebrew (he)
Other versions
IL312349B1 (en
IL312349A (en
Original Assignee
Editforce Inc
Univ Kyushu Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Editforce Inc, Univ Kyushu Nat Univ Corp filed Critical Editforce Inc
Publication of IL312349A publication Critical patent/IL312349A/en
Publication of IL312349B1 publication Critical patent/IL312349B1/en
Publication of IL312349B2 publication Critical patent/IL312349B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL312349A 2019-05-29 2020-05-29 The cause of least accumulation and use IL312349B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019100553 2019-05-29
PCT/JP2020/021473 WO2020241877A1 (ja) 2019-05-29 2020-05-29 凝集の少ないpprタンパク質及びその利用

Publications (3)

Publication Number Publication Date
IL312349A IL312349A (en) 2024-06-01
IL312349B1 IL312349B1 (en) 2024-12-01
IL312349B2 true IL312349B2 (en) 2025-04-01

Family

ID=73552159

Family Applications (2)

Application Number Title Priority Date Filing Date
IL312349A IL312349B2 (en) 2019-05-29 2020-05-29 The cause of least accumulation and use
IL288417A IL288417B2 (en) 2019-05-29 2020-05-29 PPR protein causing less aggregation and use of the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL288417A IL288417B2 (en) 2019-05-29 2020-05-29 PPR protein causing less aggregation and use of the same

Country Status (10)

Country Link
US (1) US12559528B2 (cg-RX-API-DMAC10.html)
EP (1) EP3977849A4 (cg-RX-API-DMAC10.html)
JP (4) JP7308468B2 (cg-RX-API-DMAC10.html)
KR (1) KR102898966B1 (cg-RX-API-DMAC10.html)
CN (1) CN113966340A (cg-RX-API-DMAC10.html)
AU (2) AU2020283367B2 (cg-RX-API-DMAC10.html)
CA (1) CA3142303A1 (cg-RX-API-DMAC10.html)
IL (2) IL312349B2 (cg-RX-API-DMAC10.html)
SG (1) SG11202113057XA (cg-RX-API-DMAC10.html)
WO (1) WO2020241877A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114729017A (zh) * 2019-05-29 2022-07-08 日商基因编辑力股份有限公司 Ppr蛋白的有效制作方法及其应用
JP7125727B1 (ja) 2021-09-07 2022-08-25 国立大学法人千葉大学 核酸配列改変用組成物および核酸配列の標的部位を改変する方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006188507A (ja) * 2004-12-10 2006-07-20 Tokyo Univ Of Agriculture & Technology 蛋白質の溶解度向上方法
ES2751126T3 (es) * 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
KR20160007541A (ko) * 2013-04-22 2016-01-20 고쿠리쓰다이가쿠호진 규슈다이가쿠 피피알 모티프를 이용한 디앤에이 결합성 단백질 및 그의 이용
WO2017209122A1 (ja) 2016-06-03 2017-12-07 国立大学法人九州大学 標的mRNAからのタンパク質発現量を向上させるための融合タンパク質
JPWO2018030488A1 (ja) * 2016-08-10 2019-06-13 富士フイルム和光純薬株式会社 Pprモチーフを利用したdna結合性タンパク質およびその利用
JP6918686B2 (ja) 2017-11-28 2021-08-11 東芝ライフスタイル株式会社 冷蔵庫
KR102568600B1 (ko) 2018-02-19 2023-08-23 삼성디스플레이 주식회사 표시 장치, 이를 포함하는 적층 기판, 및 표시 장치 제조방법
CN114729017A (zh) 2019-05-29 2022-07-08 日商基因编辑力股份有限公司 Ppr蛋白的有效制作方法及其应用

Also Published As

Publication number Publication date
US20220220166A1 (en) 2022-07-14
IL288417B1 (en) 2024-06-01
SG11202113057XA (en) 2021-12-30
KR102898966B1 (ko) 2025-12-10
JP7308468B2 (ja) 2023-07-14
IL288417A (en) 2022-01-01
IL288417B2 (en) 2024-10-01
JP7526399B2 (ja) 2024-08-01
WO2020241877A1 (ja) 2020-12-03
AU2020283367A1 (en) 2022-01-06
JP7749763B2 (ja) 2025-10-06
JPWO2020241877A1 (cg-RX-API-DMAC10.html) 2020-12-03
AU2020283367B2 (en) 2025-04-10
JP7880589B2 (ja) 2026-06-26
JP2023036848A (ja) 2023-03-14
US12559528B2 (en) 2026-02-24
EP3977849A4 (en) 2023-06-28
JP2025181985A (ja) 2025-12-11
NZ783357A (en) 2025-06-27
BR112021023937A2 (pt) 2022-04-19
JP2024138381A (ja) 2024-10-08
IL312349B1 (en) 2024-12-01
KR20220023984A (ko) 2022-03-03
AU2025205185A1 (en) 2025-07-31
EP3977849A1 (en) 2022-04-06
IL312349A (en) 2024-06-01
CA3142303A1 (en) 2020-12-03
CN113966340A (zh) 2022-01-21

Similar Documents

Publication Publication Date Title
IL312349A (en) causing less accumulation and use of it
EP2594581A3 (en) Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens
EP2261248A3 (en) KDR peptides and vaccines comprising the same
JP2015512246A5 (cg-RX-API-DMAC10.html)
WO2009004315A8 (en) Isolated peptides and uses thereof
WO2019094938A3 (en) Methods and compositions for the treatment of wounds
EP2508601A3 (en) Tem8 peptides and vaccines comprising the same
RU2011154363A (ru) Комбинации клад rrgb пневмококков
JP2023517293A5 (cg-RX-API-DMAC10.html)
JP2023036848A5 (cg-RX-API-DMAC10.html)
WO2024078645A3 (zh) Cas蛋白及其应用
CN119552218B (zh) 一类以ww为对称中心的低毒广谱抗菌肽及其应用
CN108395471A (zh) 抑制MERS-CoV感染的多肽
JP2019537562A5 (cg-RX-API-DMAC10.html)
DE602004025265D1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
JP7489319B2 (ja) 細胞膜透過性ペプチド
JP2022509258A5 (cg-RX-API-DMAC10.html)
JP2023145672A5 (cg-RX-API-DMAC10.html)
Leszyk et al. Caldesmon structure and function: sequence analysis of a 35 kilodalton actin-and calmodulin-binding fragment from the C-terminus of the turkey gizzard protein
RU2021139146A (ru) Белок ppr, вызывающий меньшую агрегацию, и его использование
CN111454330A (zh) 色氨酸和组氨酸跨链交互作用的β发卡抗菌肽及制备方法
RU2021139149A (ru) Эффективный способ получения белка ppr и его использование
WO2002050108A3 (fr) Glycopeptides immunogenes, criblage, préparation et applications.
JP2011512364A5 (cg-RX-API-DMAC10.html)
Ikemura et al. Heat-stable enterotoxin (STh) of human enterotoxigenic Escherichia coli (strain SK-1). Structure-activity relationship.